Anlotinib enhances the antitumor activity of high-dose irradiation combined with anti-PD-L1 by potentiating the tumor immune microenvironment in murine lung cancer

被引：0
|
作者：
Yuan, M. [1 ]
Zhai, Y. [1 ]
Hui, Z. [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
181P
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [1] Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer
    Yuan, Meng
    Zhai, Yirui
    Men, Yu
    Zhao, Maoyuan
    Sun, Xin
    Ma, Zeliang
    Bao, Yongxing
    Yang, Xu
    Sun, Shuang
    Liu, Yunsong
    Zhang, Wanting
    Hui, Zhouguang
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [2] Anlotinib enhances the antitumor activity of high-dose irradiation combined with anti-PD-L1 by potentiating the tumor immune microenvironment in murine lung cancer
    Yuan, M.
    Zhai, Y.
    Hui, Z.
    ANNALS OF ONCOLOGY, 2022, 33 : S15 - S15
  • [3] Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer
    Yuan, M.
    Zhai, Y. R.
    Hui, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S126 - S126
  • [4] Combined anti-PD-L1 and anti-VEGFR2 therapy promotes the antitumor immune response in GBM by reprogramming tumor microenvironment
    Yao, Lin
    Wang, Hao
    Liu, Yongsheng
    Feng, Ming
    Li, Yanyan
    Su, Zuopeng
    Li, Wen
    Xiong, Yun
    Gao, Heyang
    Zhou, Youxin
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [5] Modulating the tumor microenvironment improves antitumor effect of anti-PD-L1 mAb in breast cancer
    Li, Xiuying
    Luo, Xianqin
    Hu, Shunqin
    BIOIMPACTS, 2023, 13 (02) : 89 - 96
  • [6] Irradiation-Modulated Murine Brain Microenvironment Enhances GL261-Tumor Growth and Inhibits Anti-PD-L1 Immunotherapy
    Garbow, Joel R.
    Johanns, Tanner M.
    Ge, Xia
    Engelbach, John A.
    Yuan, Liya
    Dahiya, Sonika
    Tsien, Christina I.
    Gao, Feng
    Rich, Keith M.
    Ackerman, Joseph J. H.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer
    Gong, Xiaomei
    Li, Xuefei
    Jiang, Tao
    Xie, Huikang
    Zhu, Zhengfei
    Zhou, Fei
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1085 - 1097
  • [8] Degradation of hyaluronan in the tumor microenvironment enhances oncolytic reovirus and anti-PD-L1 therapy in a murine syngeneic breast tumor model
    Lee, Jisook
    Wilkinson, Grey A.
    Kimbler, Trevor
    Blouw, Barbara
    Thompson, Curtis B.
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma
    Liang, Jiahua
    Ma, Mingjian
    Feng, Wei
    Xu, Qiongcong
    Chen, Dong
    Lai, Jiaming
    Chen, Jiancong
    APOPTOSIS, 2025, 30 (1-2) : 55 - 68
  • [10] Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
    Philippou, Yiannis
    Sjoberg, Hanna T.
    Murphy, Emma
    Alyacoubi, Said
    Jones, Keaton I.
    Gordon-Weeks, Alex N.
    Phyu, Su
    Parkes, Eileen E.
    Gillies McKenna, W.
    Lamb, Alastair D.
    Gileadi, Uzi
    Cerundolo, Vincenzo
    Scheiblin, David A.
    Lockett, Stephen J.
    Wink, David A.
    Mills, Ian G.
    Hamdy, Freddie C.
    Muschel, Ruth J.
    Bryant, Richard J.
    BRITISH JOURNAL OF CANCER, 2020, 123 (07) : 1089 - 1100
12345